期刊文献+

N3期胃癌D2联合腹主动脉旁淋巴结清扫对患者生存预后的影响 被引量:25

The prognostic influence of D2 lymphadenectomy with para-aortic lymph nodal dissection for gastric cancer in N3 stage
原文传递
导出
摘要 目的 探讨N3期胃癌D2根治术腹主动脉旁淋巴结(PAL)清扫的必要性.方法 回顾性分析2003年1月至2007年12月收治的278例N3期胃癌患者的临床病理资料,其中男性180例,女性98例;中位年龄61岁(26 ~ 93岁).患者均接受手术治疗,其中R0切除246例,R1切除32例.D1淋巴结清扫125例,D2淋巴结清扫109例,D2+腹主动脉旁淋巴结清扫(PAND)44例.术式包括全胃切除98例,次全切除180例.分析淋巴结清扫范围对患者预后的影响.结果 N3期胃癌各组淋巴结转移率均较高,其中第16组淋巴结转移率达34.1%.Borrmann分型(HR=1.350,95%CI:1.018 ~ 1.790,P=0.037)、手术根治程度(HR=1.580,95%CI:1.076 ~2.322,P=0.020)、浸润深度(HR=1.697,95% CI:1.005 ~2.864,P=0.048)、淋巴结转移率(HR=1.631,95%CI:1.261~2.111,P=0.000)、软组织浸润(HR=1.336,95%CI:1.027 ~1.738,P=0.031)、术后辅助化疗(HR=1.312,95%CI:1.015 ~1.696,P=0.038)、淋巴结清扫范围(HR=1.488、2.114,P=0.054、0.000)及淋巴结检出数目(HR=1.503、2.112,P=0.025、0.000)与N3期患者预后显著相关.多因素分析显示,仅Borrmann分型(HR=1.399,95% CI:1.050 ~1.863,P=0.022)、淋巴结转移率(HR=1.353,95%CI:1.016 ~1.802,P=0.039)及清扫范围(HR=1.725,95%CI:1.111 ~2.678,P=0.015)是N3期患者的独立预后因素.结论 N3期患者至少应检出30枚淋巴结,D2+ PAND可能提高N3期胃癌患者总体生存率. Objective To elucidate the necessity of para-aortic lymph nodal dissection in D2 lymphadenectomy for gastric cancer in N3 stage.Methods A total of 278 gastric cancer patients staged N3 who underwent gastrectomy between January 2003 and December 2007 were enrolled.There were 180 male and 98 female patients,and the patients' age were 26-93 years (median was 61 years).All patients had undergone surgical treatment.There were R0 resection in 246 cases and R1 resection in 32 cases.Lymph node dissection included D1 lymphadenectomy with 125 cases,D2 lymphadenectomy with 109 cases and D2 + para-aortic lymph nodal dissection(PAND) with 44 cases.The surgical approach were total gastrectomy (98 cases) and subtotal gastrectomy (180 cases).Potential prognostic factors were analyzed.Results The lymph node metastasis of each station was high in gastric cancer patients staged N3 and 34.1% patients had the para-aortic lymph nodal metastasis.Borrmann type (HR =1.350,95% CI:1.018-1.790,P =0.037),curability (HR =1.580,95% CI:1.076-2.322,P =0.020),depth of invasion (HR =1.697,95% CI:1.005-2.864,P =0.048),metastatic lymph node ratio (HR =1.631,95% CI:1.261-2.111,P =0.000),extranodal metastasis (HR =1.336,95% CI:1.027-1.738,P =0.031),postoperative adjuvant chemotherapy (HR =1.312,95% CI:1.015-1.696,P =0.038),extent of lymphadenectomy (HR =1.488 and 2.114,P =0.054 and 0.000) and number of retrieved lymph node (HR =1.503 and 2.112,P =0.025 and 0.000) were found to be factors correlated to overall survival.In multivariate analysis,only Borrrnann type (HR =1.399,95% CI:1.050-1.863,P =0.022),metastatic lymph node ratio (HR =1.353,95% CI:1.016-1.802,P =0.039) and extent of lymphadenectomy (HR =1.725,95% CI:1.111-2.678,P =0.015) were independent prognostic factors for gastric cancer patients in N3 stage.Conclusions Patients in N3 stage should at least have 30 lymph node examined.D2 lymph node dissection plus PAND may improve the overall survival for gastric cancer patients in N3 stage.
出处 《中华外科杂志》 CAS CSCD 北大核心 2013年第12期1071-1076,共6页 Chinese Journal of Surgery
基金 国家重点研究发展计划(973计划)资助项目(2010CB529301) 天津医科大学科学基金资助项目(2010KY34)
关键词 胃肿瘤 淋巴结切除术 预后 因素分析 统计学 Stomach neoplasms Lymph node excision Prognosis Factor analysis, statistical
作者简介 通信作者:梁寒,Email:tjlianghan@126.com
  • 相关文献

参考文献3

二级参考文献51

  • 1刘统成,郑章清,何裕隆,马晋平,郑朝旭,詹文华.根治性淋巴结清扫治疗早期胃癌的价值——附19例临床分析[J].中国胃肠外科杂志,1999,2(4):220-222. 被引量:3
  • 2Parkin DM.Epidemiology of cancer global patterns and trends.Toxicol Lett,1998,28:102-103,227-234.
  • 3Howson CP,Hiyama T,Wynder EL.The decline in gastric cancer epidemiology of an unplanned triumph.Epidemiol Rev,1986,8:1-27.
  • 4Hartgrink HH,Velde CJH,Putter H,et al.Extended lymph node dissection fro gastric cancer:who may benefit? Final results of the randomized Dutch Gastric Cancer Group Trial.J Clin Oncol,2004,22:2069-2077.
  • 5太田惠一郎,大山繁和,高桥孝,他.胃癌手術の歷史的變遷.消化器外科,1997,22:1175-1184.
  • 6伊藤雅史,平山廉三,前岛静顯,他.解剖学的見地ょりみた胃リンパ系(その 1)-臟侧リンパ系を中心として-.消化器外科,1990,13:1957-1968.
  • 7铃木力,西卷正,神田達夫,他.胃癌術後の乳び瘘,リンバ瘘.手术,2001,55:1137-1142.
  • 8詹文华 汪建平 詹文华 主编.胃癌淋巴结清扫术[A].汪建平,詹文华,主编.胃肠外科手术学.第1版[C].北京:人民卫生出版社,2005.434-443.
  • 9Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
  • 10Sobin LH, Wittekind C. TNM classification of malignant tumours. 6th ed. Hoboken, NJ: John Wiley & Sons, 2002.

共引文献92

同被引文献161

引证文献25

二级引证文献160

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部